Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma

Cancer Science

Volumn 106, Issue 9, 2015, Pages 1118-1129

  Mori, Takahiro ^a   Sumii, Makiko ^a   Fujishima, Fumiyoshi ^b   Ueno, Kazuko ^c   Emi, Mitsuru ^d   Nagasaki, Masao ^c   Ishioka, Chikashi ^c   Chiba, Natsuko ^c  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

BAP1; Deubiquitinase; Esophageal squamous cell carcinoma; Gene expression profiling; Somatic mutation

Indexed keywords

ISOLEUCINE; PHENYLALANINE; BAP1 PROTEIN, HUMAN; NUCLEAR PROTEIN; TCEAL7 PROTEIN, HUMAN; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; BRCA1 ASSOCIATED PROTEIN 1 GENE; CANCER PATIENT; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; ENZYME ACTIVITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE DELETION; GENE EXPRESSION PROFILING; GENE FREQUENCY; GENE ONTOLOGY; GENE REPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MUTANT; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; SOMATIC MUTATION; TCEAL7 GENE; TUMOR SUPPRESSOR GENE; WILD TYPE; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; ESOPHAGUS TUMOR; GENETICS; MUTATION; PATHOLOGY; PROCEDURES; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84942197191     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12722     Document Type: Article

References (38)

1. Jensen DE, Proctor M, Marquis ST et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 1998; 16: 1097-112.
2. Machida YJ, Machida Y, Vashisht AA, Wohlschlegel JA, Dutta A. The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem 2009; 284: 34179-88.
3. Ventii KH, Devi NS, Friedrich KL et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res 2008; 68: 6953-62.
4. Misaghi S, Ottosen S, Izrael-Tomasevic A et al. Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol Cell Biol 2009; 29: 2181-92.
5. Mashtalir N, Daou S, Barbour H et al. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O. Mol Cell 2014; 54: 392-406.
6. Harbour JW, Onken MD, Roberson ED et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010; 330: 1410-3.
7. Bott M, Brevet M, Taylor BS et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 2011; 43: 668-72.
8. Yoshikawa Y, Sato A, Tsujimura T et al. Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma. Cancer Sci 2012; 103: 868-74.
9. Pena-Llopis S, Vega-Rubin-de-Celis S, Liao A et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 2012; 44: 751-9.
10. Jia Y, Pawlik TM, Anders RA et al. Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas. Nat Genet 2013; 45: 1470-3.
11. Chan-On W, Nairismagi ML, Ong CK et al. Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers. Nat Genet 2013; 45: 1474-8.
12. Abdel-Rahman MH, Pilarski R, Cebulla CM et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 2011; 48: 856-9.
13. Testa JR, Cheung M, Pei J et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 2011; 43: 1022-5.
14. Wiesner T, Obenauf AC, Murali R et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 2011; 43: 1018-21.
15. Carbone M, Ferris LK, Baumann F et al. BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. J Transl Med 2012; 10: 179.
16. Carbone M, Yang H, Pass HI, Krausz T, Testa JR, Gaudino G. BAP1 and cancer. Nat Rev Cancer 2013; 13: 153-9.
17. Pilarski R, Cebulla CM, Massengill JB et al. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases. Genes Chromosom Cancer 2013; 53: 177-82.
18. de la Fouchardiere A, Cabaret O, Savin L et al. Germline BAP1 mutations predispose also to multiple basal cell carcinomas. Clin Genet 2014; doi: 10.1111/cge.12472.
19. Aoki T, Mori T, Du X, Nisihira T, Matsubara T, Nakamura Y. Allelotype study of esophageal carcinoma. Genes Chromosom Cancer 1994; 10: 177-82.
20. Mori T, Yanagisawa A, Kato Y et al. Accumulation of genetic alterations during esophageal carcinogenesis. Hum Mol Genet 1994a; 3: 1969-71.
21. Okano S, Kanno S, Nakajima S, Yasui A. Cellular responses and repair of single-strand breaks introduced by UV damage endonuclease in mammalian cells. J Biol Chem 2000; 275: 32635-41.
22. Starita LM, Horwitz AA, Keogh MC, Ishioka C, Parvin JD, Chiba N. BRCA1/BARD1 ubiquitinate phosphorylated RNA polymerase II. J Biol Chem 2005; 280: 24498-505.
23. Govers R, van Kerkhof P, Schwartz AL, Strous GJ. Linkage of the ubiquitin-conjugating system and the endocytic pathway in ligand-induced internalization of the growth hormone receptor. EMBO J 1997; 16: 4851-8.
24. Wiesner T, Murali R, Fried I et al. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol 2012; 36: 818-30.
25. Chien J, Narita K, Rattan R et al. A role for candidate tumor-suppressor gene TCEAL7 in the regulation of c-Myc activity, cyclin D1 levels and cellular transformation. Oncogene 2008; 27: 7223-34.
26. Homig-Holzel C, Savola S. Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol 2012; 21: 189-206.
27. Hollstein MC, Metcalf RA, Welsh JA, Montesano R, Harris CC. Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 1990; 87: 9958-61.
28. Mori T, Miura K, Aoki T, Nishihira T, Mori S, Nakamura Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 1994b; 54: 3396-7.
29. Agrawal N, Jiao Y, Bettegowda C et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov 2012; 2: 899-905.
30. Abedi-Ardekani B, Hainaut P. Cancers of the upper gastro-intestinal tract: a review of somatic mutation distributions. Arch Iran Med 2014; 17: 286-92.
31. Song Y, Li L, Ou Y et al. Identification of genomic alterations in oesophageal squamous cell cancer. Nature 2014; 509: 91-5.
32. Gao YB, Chen ZL, Li JG et al. Genetic landscape of esophageal squamous cell carcinoma. Nat Genet 2014; 46: 1097-102.
33. Gammon B, Traczyk TN, Gerami P. Clumped perinuclear BAP1 expression is a frequent finding in sporadic epithelioid Spitz tumors. J Cutan Pathol 2013; 40: 538-42.
34. Koopmans AE, Verdijk RM, Brouwer RW et al. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol 2014; 27: 1321-30.
35. Chien J, Staub J, Avula R et al. Epigenetic silencing of TCEAL7 (Bex4) in ovarian cancer. Oncogene 2005; 24: 5089-100.
36. Lafferty-whyte K, Bilstand A, Hoare SF et al. TCEAL7 inhibition of c-Mys activity in alternative lengthening of telomeres regulates hTERT expression. Neoplasm 2010; 12: 405-14.
37. Rattan R, Narita K, Chien J et al. TCEAL7, a putative tumor suppressor gene, negatively regulates NF-κB pathway. Oncogene 2010; 29: 1362-73.
38. Shi X, Garry DJ. Myogenic regulatory factors transacitivate the Tceal7 gene and modulate muscle differentiation. Biochem J 2010; 428: 213-21.